Colnot Thomas, Dekant Wolfgang
CiS Toxicology, Osorno, Chile.
Department of Toxicology, University of Würzburg, Versbacher Strasse 9, 97078, Würzburg, Germany.
Regul Toxicol Pharmacol. 2017 Feb;83:89-99. doi: 10.1016/j.yrtph.2016.12.004. Epub 2016 Dec 10.
The European Food Safety Authority (EFSA) is developing approaches to cumulative risk assessment of pesticides by assigning individual pesticides to cumulative assessment groups (CAGs). For assignment to CAGs, EFSA recommended to rely on adverse effects on the specific target system. Contractors to EFSA have proposed to allocate individual pesticides into CAGs relying on NOAELs for effects on target organs. This manuscript evaluates the assignments by applying EFSAs criteria to the CAGs "Toxicity to the nervous system" and "Toxicity to the thyroid hormone system (gland or hormones)". Assignment to the CAG "Toxicity to the nervous system" based, for example, on neurochemical effects like choline esterase inhibition is well supported, whereas assignment to the CAG "Toxicity to the thyroid hormone system (gland or hormones)" has been based in the examined case studies on non-reproducible effects seen in single studies or on observations that are not adverse. Therefore, a more detailed effects evaluation is required to assign a pesticide to a CAG for a target organ where many confounders regarding effects are present. Relative potency factors in cumulative risk assessment should be based on benchmark doses from studies in one species with identical study design and human relevance of effects on specific target organs should be analyzed to define minimal margins of exposure.
欧洲食品安全局(EFSA)正在通过将单一农药分配到累积评估组(CAG)来制定农药累积风险评估方法。为了将农药分配到CAG中,EFSA建议依据对特定目标系统的不良影响来进行。EFSA的承包商提议根据对靶器官影响的无可见有害作用水平(NOAEL)将单一农药分配到CAG中。本手稿通过将EFSA的标准应用于“对神经系统的毒性”和“对甲状腺激素系统(腺体或激素)的毒性”这两个CAG,对这些分配情况进行了评估。例如,基于胆碱酯酶抑制等神经化学效应而分配到“对神经系统的毒性”CAG中是有充分依据的,而在已审查的案例研究中,分配到“对甲状腺激素系统(腺体或激素)的毒性”CAG则是基于单一研究中出现的不可重复效应或非不良的观察结果。因此,对于存在许多影响混杂因素的靶器官,若要将一种农药分配到某个CAG中,就需要进行更详细的效应评估。累积风险评估中的相对效力因子应基于同一物种、具有相同研究设计的研究中的基准剂量,并且应分析对特定靶器官影响的人体相关性,以确定最小暴露边际。